X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-litigation-for-cysteamine-bitartrate-1646027894.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-21-2020-1603260774.pdf
https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-procysbi-203389-cysteamine-bitartrate-delayed-release-capsules25-mg-and-75-mg-1593588247.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213491
https://www.reuters.com/article/us-recordati-canada/recordati-to-seek-canadian-approval-for-kidney-disease-drug-idUSKCN1RS1YP?feedType=RSS&feedName=healthNews
https://www.raps.org/news-and-articles/news-articles/2018/3/canadian-government-is-investigating-price-of-gene?utm_source=Email&utm_medium=Informz&utm_campaign=Informz-Emails&_zs=VHOsL1&_zl=BieN4
http://ir.horizon-pharma.com/news-releases/news-release-details/horizon-pharma-plc-completes-sale-european-marketing-rights
http://ir.horizon-pharma.com/news-releases/news-release-details/horizon-pharma-plc-announces-health-canada-approval-procysbitm
http://www.nasdaq.com/press-release/horizon-pharma-plc-announces-agreement-to-sell-european-marketing-rights-to-procysbi-cysteamine-20170523-01193
https://www.thestreet.com/story/13727391/1/more-rare-disease-dealmaking-to-follow-horizon-s-raptor-deal.html
http://in.reuters.com/article/2015/09/14/us-raptor-pharmactl-study-idINKCN0RE15V20150914
Market Place
Share 
